US Stock MarketDetailed Quotes

TNFA TNF Pharmaceuticals

Watchlist
  • 1.360
  • -0.110-7.48%
Close Dec 20 16:00 ET
  • 1.380
  • +0.020+1.47%
Post 20:01 ET
3.75MMarket Cap-0.10P/E (TTM)

TNF Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
0
0
0
0
0
0
0
0
Gross profit
0
0
0
0
0
0
0
0
0
0
Operating expense
-52.49%1.83M
-67.81%1.86M
52.37%2.78M
7.05%16.36M
28.90%4.91M
3.58%3.84M
58.71%5.78M
-55.66%1.83M
-45.81%15.28M
21.81%3.81M
Selling and administrative expenses
-42.09%1.12M
-58.96%1.46M
50.01%1.59M
36.64%8.49M
45.63%1.95M
1.24%1.93M
140.51%3.56M
-29.16%1.06M
-71.03%6.22M
-44.26%1.34M
-General and administrative expense
-42.09%1.12M
-58.96%1.46M
50.01%1.59M
36.64%8.49M
45.63%1.95M
1.24%1.93M
140.51%3.56M
-29.16%1.06M
-71.03%6.22M
-44.26%1.34M
Research and development costs
-62.99%707.75K
-81.97%401.1K
55.62%1.2M
-13.23%7.87M
19.84%2.96M
6.05%1.91M
2.79%2.22M
-70.70%770.43K
34.43%9.07M
240.03%2.47M
Operating profit
52.49%-1.83M
67.81%-1.86M
-52.37%-2.78M
-7.05%-16.36M
-28.90%-4.91M
-3.58%-3.84M
-58.71%-5.78M
55.66%-1.83M
45.81%-15.28M
-21.81%-3.81M
Net non-operating interest income expense
17.90%163.95K
-87.91%21.15K
-29.11%18.31K
442.40%455.57K
85.54%115.84K
799.86%139.06K
2,821.00%174.85K
21,420.00%25.82K
114.01%83.99K
-33.71%62.43K
Non-operating interest income
17.90%163.95K
-87.91%21.15K
-29.11%18.31K
442.40%455.57K
85.54%115.84K
799.86%139.06K
2,821.00%174.85K
21,420.00%25.82K
842.98%83.99K
3,922.68%62.43K
Other net income (expense)
-103.46%-267.7K
-636.84%-7.73M
-2,526.02%-7.03M
828,917.97%11.9M
2,729,242.70%2.43M
1,108,129.76%7.75M
151,706.75%1.44M
96,743.00%289.93K
100.13%1.44K
100.04%89
Gain on sale of security
-104.65%-368.25K
-22.16%1.12M
-768.12%-7.03M
427,436.33%12.85M
67,142.75%3.19M
417,236.70%7.93M
151,706.75%1.44M
22,300.82%1.05M
5.94%-3.01K
-112.11%-4.76K
Earnings from equity interest
210.20%551
----
----
----
----
58.33%-500
----
----
----
----
Special income (charges)
156.12%100K
----
--0
-21,284.87%-941.03K
---762.83K
---178.2K
----
-17,273.21%-762.83K
100.41%4.44K
--0
-Less:Other special charges
-156.12%-100K
----
----
21,284.87%941.03K
--762.83K
--178.2K
----
17,273.21%762.83K
-100.41%-4.44K
--0
Other non- operating income (expenses)
----
---8.85M
----
----
----
----
----
----
----
----
Income before tax
-147.72%-1.93M
-129.52%-9.57M
-548.27%-9.8M
73.68%-4M
36.90%-2.36M
209.46%4.04M
-14.62%-4.17M
63.33%-1.51M
49.15%-15.2M
-15.61%-3.75M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-147.72%-1.93M
-129.52%-9.57M
-548.27%-9.8M
73.68%-4M
36.90%-2.36M
209.46%4.04M
-14.62%-4.17M
63.33%-1.51M
49.15%-15.2M
-15.61%-3.75M
Net income continuous Operations
-147.72%-1.93M
-129.52%-9.57M
-548.27%-9.8M
73.68%-4M
36.90%-2.36M
209.46%4.04M
-14.62%-4.17M
63.33%-1.51M
49.15%-15.2M
-15.61%-3.75M
Minority interest income
Net income attributable to the parent company
-147.72%-1.93M
-129.52%-9.57M
-548.27%-9.8M
73.68%-4M
36.90%-2.36M
209.46%4.04M
-14.62%-4.17M
63.33%-1.51M
49.15%-15.2M
-15.61%-3.75M
Preferred stock dividends
-35.15%751.05K
107.96%777.34K
659.08%1.2M
4.22M
2.53M
1.16M
373.8K
158.33K
Other preferred stock dividends
Net income attributable to common stockholders
-192.91%-2.68M
-127.75%-10.34M
-558.77%-11M
45.92%-8.22M
-30.60%-4.89M
178.10%2.88M
-24.90%-4.54M
59.48%-1.67M
49.15%-15.2M
-15.61%-3.75M
Basic earnings per share
-160.33%-1.11
-40.99%-4.54
-328.33%-5.14
54.60%-5.33
-11.31%-3.05
168.15%1.84
-19.26%-3.22
63.64%-1.2
53.96%-11.74
-30.48%-2.74
Diluted earnings per share
-400.00%-1.11
-40.99%-4.54
-328.33%-5.14
54.60%-5.33
-11.31%-3.05
113.70%0.37
-19.26%-3.22
63.64%-1.2
53.96%-11.74
-30.48%-2.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0000000000
Gross profit 0000000000
Operating expense -52.49%1.83M-67.81%1.86M52.37%2.78M7.05%16.36M28.90%4.91M3.58%3.84M58.71%5.78M-55.66%1.83M-45.81%15.28M21.81%3.81M
Selling and administrative expenses -42.09%1.12M-58.96%1.46M50.01%1.59M36.64%8.49M45.63%1.95M1.24%1.93M140.51%3.56M-29.16%1.06M-71.03%6.22M-44.26%1.34M
-General and administrative expense -42.09%1.12M-58.96%1.46M50.01%1.59M36.64%8.49M45.63%1.95M1.24%1.93M140.51%3.56M-29.16%1.06M-71.03%6.22M-44.26%1.34M
Research and development costs -62.99%707.75K-81.97%401.1K55.62%1.2M-13.23%7.87M19.84%2.96M6.05%1.91M2.79%2.22M-70.70%770.43K34.43%9.07M240.03%2.47M
Operating profit 52.49%-1.83M67.81%-1.86M-52.37%-2.78M-7.05%-16.36M-28.90%-4.91M-3.58%-3.84M-58.71%-5.78M55.66%-1.83M45.81%-15.28M-21.81%-3.81M
Net non-operating interest income expense 17.90%163.95K-87.91%21.15K-29.11%18.31K442.40%455.57K85.54%115.84K799.86%139.06K2,821.00%174.85K21,420.00%25.82K114.01%83.99K-33.71%62.43K
Non-operating interest income 17.90%163.95K-87.91%21.15K-29.11%18.31K442.40%455.57K85.54%115.84K799.86%139.06K2,821.00%174.85K21,420.00%25.82K842.98%83.99K3,922.68%62.43K
Other net income (expense) -103.46%-267.7K-636.84%-7.73M-2,526.02%-7.03M828,917.97%11.9M2,729,242.70%2.43M1,108,129.76%7.75M151,706.75%1.44M96,743.00%289.93K100.13%1.44K100.04%89
Gain on sale of security -104.65%-368.25K-22.16%1.12M-768.12%-7.03M427,436.33%12.85M67,142.75%3.19M417,236.70%7.93M151,706.75%1.44M22,300.82%1.05M5.94%-3.01K-112.11%-4.76K
Earnings from equity interest 210.20%551----------------58.33%-500----------------
Special income (charges) 156.12%100K------0-21,284.87%-941.03K---762.83K---178.2K-----17,273.21%-762.83K100.41%4.44K--0
-Less:Other special charges -156.12%-100K--------21,284.87%941.03K--762.83K--178.2K----17,273.21%762.83K-100.41%-4.44K--0
Other non- operating income (expenses) -------8.85M--------------------------------
Income before tax -147.72%-1.93M-129.52%-9.57M-548.27%-9.8M73.68%-4M36.90%-2.36M209.46%4.04M-14.62%-4.17M63.33%-1.51M49.15%-15.2M-15.61%-3.75M
Income tax 0000000000
Net income -147.72%-1.93M-129.52%-9.57M-548.27%-9.8M73.68%-4M36.90%-2.36M209.46%4.04M-14.62%-4.17M63.33%-1.51M49.15%-15.2M-15.61%-3.75M
Net income continuous Operations -147.72%-1.93M-129.52%-9.57M-548.27%-9.8M73.68%-4M36.90%-2.36M209.46%4.04M-14.62%-4.17M63.33%-1.51M49.15%-15.2M-15.61%-3.75M
Minority interest income
Net income attributable to the parent company -147.72%-1.93M-129.52%-9.57M-548.27%-9.8M73.68%-4M36.90%-2.36M209.46%4.04M-14.62%-4.17M63.33%-1.51M49.15%-15.2M-15.61%-3.75M
Preferred stock dividends -35.15%751.05K107.96%777.34K659.08%1.2M4.22M2.53M1.16M373.8K158.33K
Other preferred stock dividends
Net income attributable to common stockholders -192.91%-2.68M-127.75%-10.34M-558.77%-11M45.92%-8.22M-30.60%-4.89M178.10%2.88M-24.90%-4.54M59.48%-1.67M49.15%-15.2M-15.61%-3.75M
Basic earnings per share -160.33%-1.11-40.99%-4.54-328.33%-5.1454.60%-5.33-11.31%-3.05168.15%1.84-19.26%-3.2263.64%-1.253.96%-11.74-30.48%-2.74
Diluted earnings per share -400.00%-1.11-40.99%-4.54-328.33%-5.1454.60%-5.33-11.31%-3.05113.70%0.37-19.26%-3.2263.64%-1.253.96%-11.74-30.48%-2.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.